권호기사보기
기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
---|
대표형(전거형, Authority) | 생물정보 | 이형(異形, Variant) | 소속 | 직위 | 직업 | 활동분야 | 주기 | 서지 | |
---|---|---|---|---|---|---|---|---|---|
연구/단체명을 입력해주세요. |
|
|
|
|
|
* 주제를 선택하시면 검색 상세로 이동합니다.
Purpose: Studies on intestinal Behçet’s disease (BD) complicated by myelodysplastic syndrome (MDS) are rare, and no established therapeutic guidelines exist. This study aimed to evaluate the clinical presentation and outcomes of patients with intestinal BD complicated by MDS (intestinal BD–MDS) and suggest a treatment strategy.
Materials and Methods: Data from patients with intestinal BD–MDS from four referral centers in Korea who were diagnosed between December 2000 and December 2022 were retrospectively analyzed. Clinical features and prognosis of intestinal BD–MDS compared with age-, sex-matched intestinal BD without MDS were investigated.
Results: Thirty-five patients with intestinal BD–MDS were included, and 24 (70.6%) had trisomy 8. Among the 35 patients, 23 (65.7%) were female, and the median age at diagnosis for intestinal BD was 46.0 years (range, 37.0–56.0 years). Medical treatments only benefited eight of the 32 patients, and half of the patients underwent surgery due to complications. Compared to 70 matched patients with intestinal BD alone, patients with intestinal BD–MDS underwent surgery more frequently (51.4% vs. 24.3%; p=0.010), showed a poorer response to medical and/or surgical treatment (75.0% vs. 11.4%; p〈0.001), and had a higher mortality (28.6% vs. 0%; p〈0.001). Seven out of 35 patients with intestinal BD–MDS underwent hematopoietic stem cell transplantation (HSCT), and four out of the seven patients had a poor response to medical treatment prior to HSCT, resulting in complete remission of both diseases.
Conclusion: Patients with intestinal BD–MDS frequently have refractory diseases with high mortalities. HSCT can be an effective treatment modality for medically refractory patients with intestinal BD–MDS.
기사명 | 저자명 | 페이지 | 원문 | 목차 |
---|---|---|---|---|
Recent update on acute kidney injury-to-chronic kidney disease transition | Eun Sil Koh, Sungjin Chung | p. 247-256 |
|
|
Simultaneous viability assessment and invasive coronary angiography using a therapeutic CT system in chronic myocardial infarction patients | Seongmin Ha, Yeonggul Jang, Byoung Kwon Lee, Youngtaek Hong, Byeong-Keuk Kim, Seil Park, Sun Kook Yoo, Hyuk-Jae Chang | p. 257-264, [1-4] |
|
|
Optimal treatment approaches to intestinal Behçet's disease complicated by myelodysplastic syndrome : the KASID and KSBD multicenter study | Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park | p. 265-275, [1] |
|
|
Safety of biologics and small molecules for inflammatory bowel diseases in organ transplant recipients | Ga Hee Kim, Minjun Kim, Kyuwon Kim, Jung-Bin Park, Ji Eun Baek, June Hwa Bae, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park | p. 276-282 |
|
|
Diffusion- and perfusion-weighted MRI radiomics for survival prediction in patients with lower-grade gliomas | Chae Jung Park, Sooyon Kim, Kyunghwa Han, Sung Soo Ahn, Dain Kim, Yae Won Park, Jong Hee Chang, Se Hoon Kim, Seung-Koo Lee | p. 283-292, [1-3] |
|
|
Prediction of high-risk neuroblastoma among neuroblastic tumors using radiomics features derived from magnetic resonance imaging : a pilot study | Jisoo Kim, Young Hun Choi, Haesung Yoon, Hyun Ji Lim, Jung Woo Han, Mi-Jung Lee | p. 293-301, [1] |
|
|
Interrupting effect of social distancing on ischemic heart disease, asthma, stroke, and suicide attempt patients by PM2.5 exposure | Minseo Choi, Mia Son, Sanghyuk Bae, Whanhee Lee, Kyung-Nam Kim, Jung K Hyun | p. 302-313, [1-29] |
|
번호 | 참고문헌 | 국회도서관 소장유무 |
---|---|---|
1 | Beh�et's disease associated with myelodysplastic syndromes | 미소장 |
2 | Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study | 미소장 |
3 | Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease | 미소장 |
4 | Successful Treatment of Myelodysplastic Syndrome (MDS)-related intestinal Behcet's Disease by Up-front Cord Blood Transplantation | 미소장 |
5 | Gastrointestinal Behçet's disease: A review | 미소장 |
6 | Myelodysplastic Syndrome Complicated with Inflammatory Intestinal Ulcers: Significance of Trisomy 8 | 미소장 |
7 | Cytogenetic features in myelodysplastic syndromes | 미소장 |
8 | Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach | 미소장 |
9 | Behçet disease (Behçet syndrome) | 미소장 |
10 | Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes | 미소장 |
11 | The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies | 미소장 |
12 | Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution | 미소장 |
13 | Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities | 미소장 |
14 | Systemic and immune manifestations in myelodysplasia: A multicenter retrospective study | 미소장 |
15 | Gastrointestinal Manifestations of Behçet’s Disease | 미소장 |
16 | Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behcet disease | 미소장 |
17 | Clinical Effect of Point Mutations in Myelodysplastic Syndromes | 미소장 |
18 | Refractoriness of Intestinal Behçet's Disease with Myelodysplastic Syndrome Involving Trisomy 8 to Medical Therapies - Our Case Experience and Review of the Literature | 미소장 |
19 | Evidence for a Role of TNF-Related Apoptosis-Inducing Ligand (TRAIL) in the Anemia of Myelodysplastic Syndromes | 미소장 |
20 | Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes | 미소장 |
21 | Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study | 미소장 |
22 | Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8 | 미소장 |
23 | Behçet’s disease associated with myelodysplastic syndrome with elevated levels of inflammatory cytokines | 미소장 |
24 | Clinical Features of Intestinal Behçet's Disease Associated with Myelodysplastic Syndrome and Trisomy 8. | 미소장 |
25 | Autoimmune diseases and myelodysplastic syndromes | 미소장 |
26 | Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis. | 미소장 |
27 | A reappraisal of the association between Behçet's disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review. | 미소장 |
28 | Revised International Prognostic Scoring System for Myelodysplastic Syndromes | 미소장 |
29 | Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease | 미소장 |
30 | Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease | 미소장 |
31 | Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes | 미소장 |
32 | High Incidence of Gastrointestinal Ulceration and Cytogenetic Aberration of Trisomy 8 as Typical Features of Behçet’s Disease Associated with Myelodysplastic Syndrome: A Series of 16 Consecutive Chinese Patients from the Shanghai Behçet’s Disease Database and Comparison with the Literature | 미소장 |
33 | Gastrointestinal Behcet’s-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review | 미소장 |
34 | Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation | 미소장 |
35 | How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review | 미소장 |
36 | Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 | 미소장 |
37 | Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants | 미소장 |
38 | Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study | 미소장 |
39 | Use of thiopurines in inflammatory bowel disease: an update | 미소장 |
40 | Behçet's Disease | 미소장 |
41 | Behçet's Disease | 미소장 |
42 | Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis | 미소장 |
43 | Myelodysplastic syndromes | 미소장 |
44 | Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease | 미소장 |
*표시는 필수 입력사항입니다.
*전화번호 | ※ '-' 없이 휴대폰번호를 입력하세요 |
---|
기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
---|
번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
---|
도서위치안내: 정기간행물실(524호) / 서가번호: 대학01
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.